Alto Neuroscience Inc. (ANRO)
NYSE: ANRO
· Real-Time Price · USD
3.40
-0.03 (-0.87%)
At close: Aug 20, 2025, 3:15 PM
Alto Neuroscience Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -64.86M | -63.18M | -61.43M | -57.45M | -49.8M | -42.44M | -36.3M | -32.74M | -23.6M | -14.94M | -7.65M |
Depreciation & Amortization | 645K | 589K | 515K | 437K | 365K | 352K | 341K | 346K | 283K | 183K | 97K |
Stock-Based Compensation | 7.54M | 7.42M | 7.63M | 6.67M | 5.21M | 4.59M | 2.89M | 3.23M | 2.69M | 1.43M | 941K |
Other Working Capital | -1.16M | 526K | 3.54M | 2.63M | 1.43M | -1.16M | -66K | -621K | -1.8M | -895K | -605K |
Other Non-Cash Items | 7.33M | 6.48M | 5.76M | 4.79M | 626K | -257K | 838K | 1.51M | 1.57M | 1.55M | 40K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -5.74M | -4.3M | 99K | -375K | 1.63M | 804K | 83K | 1.28M | 442K | -158K | 818K |
Operating Cash Flow | -55.08M | -53M | -47.42M | -45.93M | -41.97M | -36.91M | -33.45M | -27.95M | -20.18M | -13.54M | -6.02M |
Capital Expenditures | -1.53M | -1.88M | -2.08M | -1.92M | -959K | -673K | -470K | -180K | -137K | -83K | -62K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.53M | -1.88M | -2.08M | -1.92M | -959K | -673K | -470K | -180K | -137K | -83K | -62K |
Debt Repayment | 10.72M | 10.72M | 1.25M | 1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 137.69M | 137.08M | 134.61M | -4.92M | -4.81M | -4.81M | -1.79M | 9.78M | 9.67M | 9.67M | 9.67M |
Financial Cash Flow | 11.11M | 10.26M | 135.69M | 178.77M | 177.51M | 177.69M | 68.13M | 44.71M | 44.66M | 44.71M | 19.71M |
Net Cash Flow | -45.54M | -44.64M | 86.18M | 130.91M | 134.59M | 140.12M | 34.2M | 16.59M | 24.33M | 31.09M | 13.65M |
Free Cash Flow | -56.62M | -54.87M | -49.5M | -47.85M | -42.92M | -37.58M | -33.92M | -28.13M | -20.32M | -13.63M | -6.08M |